trenzyme GmbH is a privately owned ISO 9001:2015 certified German Contract Research Organization (CRO) founded in 2000. As a full-service provider for the life science industry, it offers highly customized services in cell line development, iPSC differentiation, and recombinant protein production. The company caters to the research and development departments of academic institutes, biotechnology, and pharmaceutical companies worldwide. Their services include manufacturing of customized and standard proteins, fast delivery of microbial and mammalian proteins, GMP-compliant mammalian cell lines, and toxicity testing and tissue diagnostics. With its clear mission of accelerating innovation, trenzyme aims to save valuable research time and budget for its clients. The company also offers SARS CoV-2 proteins for research use and provides easy access to its services through a user-friendly webshop. As a leading player in the biotechnology and manufacturing industries, trenzyme GmbH presents an exciting opportunity for venture capitalists looking to invest in cutting-edge research and development support services.
There is no investment information
No recent news or press coverage available for trenzyme GmbH.